GO:0070160 tight junction: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070160 (tight junction) is a cell-cell junction that seals epithelial cells together, preventing even small molecules from leaking across the cell sheet.
• Tight junctions are composed of transmembrane proteins such as claudins, occludin, and JAMs, which assemble into strand networks linked to the actin cytoskeleton via scaffold proteins like ZO-1.
• They regulate paracellular permeability and are central to barrier function in the gut, kidney, liver, and blood-brain barrier.
• Dysregulation of tight junctions is implicated in inflammatory bowel disease, celiac disease, biliary diseases, and bacterial infections affecting the brain.
• Tight junction modulators are being developed to reversibly open the barrier for drug delivery.
• CRISPR-based models (knockout, knock-in, point mutation, overexpression) enable causal dissection of tight junction gene function in epithelial biology.
Description
Tight junctions are the primary intercellular junctions that seal epithelial and endothelial cell sheets, forming a barrier that controls the passage of ions, water, and solutes through the paracellular space. They are essential for tissue homeostasis, and their dysfunction is linked to a wide range of human diseases, including inflammatory bowel disease, celiac disease, and bacterial infections that breach the blood-brain barrier. Understanding the molecular composition and regulation of tight junctions is therefore critical for both basic cell biology and translational research. Recent advances have revealed that tight junctions are not static structures but dynamic, regulated complexes that respond to physiological and pathological stimuli. This article provides a comprehensive overview of GO:0070160, covering its definition, structure, molecular mechanisms, key genes, disease associations, and research methods, with a focus on how CRISPR-based models can accelerate discovery in this field.
tight junction At A Glance
| GO ID | GO:0070160 |
|---|---|
| GO term | tight junction |
| Ontology | cellular_component |
| Synonym | occluding cell junction, occluding junction |
| Major function | Seals cells together in an epithelium to prevent leakage of small molecules |
| Location | Apical-most region of the lateral membrane of epithelial and endothelial cells |
| Key components | Claudins, occludin, JAMs, ZO-1, actin cytoskeleton |
| Regulation | Dynamic assembly and disassembly regulated by phosphorylation, cytokines, and pathogens |
What Is GO:0070160?
GO:0070160 (tight junction) is defined as a cell-cell junction that seals cells together in an epithelium in a way that prevents even small molecules from leaking from one side of the sheet to the other. This definition captures the essential barrier function of tight junctions, which are located at the apical-most region of the lateral membrane of epithelial cells. Tight junctions are composed of transmembrane proteins, cytoplasmic scaffold proteins, and associated signaling molecules that together form a dynamic seal. They are distinct from other cell-cell junctions, such as adherens junctions and desmosomes, by their unique ability to restrict paracellular diffusion.
Why Is tight junction Important in Cell Biology?
Tight junctions are fundamental to epithelial and endothelial barrier function, and their dysregulation contributes to a broad spectrum of human diseases, including gastrointestinal disorders, biliary diseases, and neuroinflammatory conditions. They also represent a major obstacle to drug delivery, as the barrier restricts the paracellular transport of therapeutic molecules. Understanding tight junction biology is therefore essential for developing strategies to modulate barrier function in disease and for enhancing drug absorption.
• Maintains epithelial barrier integrity in the gut, kidney, liver, and blood-brain barrier.
• Dysregulation is associated with inflammatory bowel disease and celiac disease.
• Implicated in biliary diseases such as cholestasis and biliary atresia.
• Targeted by bacterial pathogens that disrupt the blood-brain barrier.
• Serves as a target for drug delivery modulators to open the paracellular route.
• Plays a role in cancer progression and metastasis through loss of barrier function.
• Involved in developmental processes and tissue morphogenesis.
• Provides a model system for studying protein-protein interactions at cell-cell contacts.
• Regulated by signaling pathways including cytokines and kinases.
• Offers opportunities for CRISPR-based functional genomics.
Structure and Composition of tight junction
Transmembrane proteins: claudins and occludin
In simple terms: These are the proteins that physically seal the space between cells.
Claudins are the primary transmembrane proteins that form the backbone of tight junction strands, with different claudin isoforms determining barrier tightness and ion selectivity. Occludin is another transmembrane protein that contributes to barrier function and is involved in signaling, although its precise role is still under investigation. Both claudins and occludin interact with cytoplasmic scaffold proteins to anchor the junction to the cytoskeleton.
Junctional adhesion molecules (JAMs)
In simple terms: These are adhesion proteins that help organize the junction and regulate cell polarity.
JAMs are immunoglobulin superfamily proteins that localize to tight junctions and participate in cell-cell adhesion, leukocyte transmigration, and signaling. They interact with scaffold proteins such as ZO-1 and are important for the assembly and maintenance of tight junctions.
Cytoplasmic scaffold proteins: ZO-1, ZO-2, ZO-3
In simple terms: These are adaptor proteins that link the transmembrane proteins to the actin cytoskeleton.
The zonula occludens (ZO) proteins, including ZO-1, ZO-2, and ZO-3, are membrane-associated guanylate kinase (MAGUK) family proteins that bind to the cytoplasmic tails of claudins and occludin. They serve as scaffolds that connect tight junction strands to the actin cytoskeleton and recruit signaling molecules. ZO-1 is a widely used marker for tight junctions.
Actin cytoskeleton and signaling complexes
In simple terms: The cytoskeleton provides mechanical support and dynamic regulation of the junction.
The actin cytoskeleton is intimately associated with tight junctions and is required for their assembly and function. Signaling proteins such as kinases and phosphatases are recruited to the junction and regulate its permeability in response to physiological and pathological stimuli.
Assembly and strand formation
In simple terms: Tight junctions form through a stepwise assembly of proteins into strand networks.
Tight junction assembly begins with the formation of primordial junctions, followed by the recruitment of claudins and occludin, which polymerize into strand networks. These strands are visualized by freeze-fracture electron microscopy as a network of continuous and branching fibrils. The assembly process is regulated by phosphorylation and interactions with the cytoskeleton.
Key Genes Involved in GO:0070160 tight junction
The following genes encode key tight junction proteins and regulators that are commonly studied in epithelial barrier research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CLDN1 | Transmembrane claudin; forms paracellular barrier | Barrier function, cancer, skin disorders |
| CLDN2 | Transmembrane claudin; forms cation-selective pores | Gut permeability, inflammatory bowel disease |
| CLDN3 | Transmembrane claudin; barrier tightening | Cancer, epithelial polarity |
| CLDN4 | Transmembrane claudin; barrier function | Cancer, drug delivery |
| CLDN5 | Transmembrane claudin; blood-brain barrier | Neuroinflammation, bacterial infection |
| OCLN | Transmembrane occludin; barrier and signaling | Barrier regulation, viral entry |
| TJP1 | Scaffold protein ZO-1; links transmembrane proteins to actin | Junction assembly, signaling |
| TJP2 | Scaffold protein ZO-2; junction assembly | Barrier function, cancer |
| TJP3 | Scaffold protein ZO-3; junction assembly | Barrier function |
| JAM-A | Junctional adhesion molecule; cell adhesion and signaling | Leukocyte transmigration, barrier |
| JAM-B | Junctional adhesion molecule; cell polarity | Spermatogenesis, barrier |
| JAM-C | Junctional adhesion molecule; cell adhesion | Inflammation, cancer |
| MYH9 | Non-muscle myosin heavy chain; cytoskeletal tension | Junction dynamics |
| ACTB | Beta-actin; cytoskeletal component | Junction assembly |
| CDH1 | E-cadherin; adherens junction crosstalk | Epithelial polarity |
| PRKCI | Protein kinase C iota; polarity regulation | Junction assembly |
| SCRIB | Scaffold protein; polarity regulation | Junction positioning |
How Is tight junction Regulated?
Tight junction assembly and permeability are dynamically regulated by multiple signaling pathways, including protein kinase C (PKC), Rho GTPases, and mitogen-activated protein kinases (MAPKs). Cytokines such as TNF-alpha and IFN-gamma increase barrier permeability by downregulating claudin expression and disrupting junctional complexes. Bacterial pathogens can modulate tight junctions through secreted effectors, leading to barrier disruption. Additionally, phosphorylation of tight junction proteins by kinases such as PKC and casein kinase 2 regulates their localization and function.
tight junction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CLDN2 | Inflammatory bowel disease | Intestinal epithelial cell knockout |
| CLDN5 | Blood-brain barrier disruption in meningitis | Brain endothelial cell knockout |
| TJP1 | Barrier dysfunction in colitis | Caco-2 cell knockout |
| OCLN | Celiac disease | Intestinal organoid knockout |
| CLDN1 | Biliary diseases | Cholangiocyte knockout |
Inflammatory bowel disease and celiac disease
Increased intestinal permeability due to tight junction dysfunction is a hallmark of inflammatory bowel disease and celiac disease. In celiac disease, gliadin peptides trigger the release of zonulin, which disassembles tight junctions and increases paracellular permeability. This leads to chronic inflammation and tissue damage.
Biliary diseases
Tight junction proteins are critical for bile duct barrier function, and their dysregulation contributes to biliary diseases such as cholestasis and biliary atresia. Altered expression of claudins and ZO-1 has been observed in cholestatic liver diseases.
Blood-brain barrier and bacterial infections
The blood-brain barrier is formed by tight junctions between brain endothelial cells, and bacterial pathogens such as Streptococcus pneumoniae and Neisseria meningitidis can disrupt these junctions to invade the central nervous system. This disruption contributes to meningitis and neuroinflammation.
Cancer
Loss of tight junction integrity is associated with cancer progression and metastasis, as it facilitates the dissociation of cells from the primary tumor. Altered expression of claudins and other tight junction proteins has been reported in various carcinomas.
From tight junction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CLDN2 increase paracellular permeability? | CLDN2 knockout in Caco-2 cells |
| Does a point mutation in CLDN5 affect blood-brain barrier tightness? | CLDN5 point mutation knock-in in brain endothelial cells |
| Can overexpression of OCLN restore barrier function? | OCLN overexpression in intestinal epithelial cells |
| How does ZO-1 tagging affect junction assembly? | TJP1 knock-in with fluorescent tag |
| What is the role of JAM-A in leukocyte transmigration? | JAM-A knockout in endothelial cells |
| Does claudin-4 modulation enhance drug delivery? | CLDN4 knockout or knockdown in epithelial cells |
How to Study the tight junction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| TEER | Barrier tightness | Evaluating knockout effects on permeability |
| Paracellular flux | Permeability to tracers | Assessing barrier function |
| Immunofluorescence | Protein localization | Visualizing junction structure |
| Freeze-fracture EM | Strand network morphology | Ultrastructural analysis |
| Proteomics | Protein composition | Identifying junction components |
| CRISPR screen | Gene function | Discovering regulators |
| Co-IP | Protein interactions | Mapping junction complexes |
| Western blot | Protein expression | Quantifying claudins and ZO-1 |
Measuring barrier function
Transepithelial electrical resistance (TEER) and paracellular flux assays using tracers such as FITC-dextran are standard methods to assess tight junction barrier function in vitro. These methods quantify the permeability of epithelial cell monolayers and are widely used to evaluate the effects of genetic manipulations.
Imaging tight junction structure
Immunofluorescence microscopy with antibodies against ZO-1, occludin, and claudins visualizes tight junction morphology and localization. Freeze-fracture electron microscopy provides high-resolution views of tight junction strand networks.
Proteomic and interactomic approaches
Mass spectrometry-based proteomics can identify tight junction-associated proteins and their post-translational modifications. Proximity ligation assays and co-immunoprecipitation are used to study protein-protein interactions at the junction.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes that regulate tight junction assembly and barrier function. These screens are powerful for discovering novel regulators and potential therapeutic targets.
How CRISPR Can Be Used to Study GO:0070160 tight junction
Knockout
CRISPR knockout of tight junction genes such as CLDN2, OCLN, or TJP1 in epithelial cell lines (e.g., Caco-2, MDCK) enables the study of their role in barrier function. Knockout models have revealed that loss of specific claudins leads to increased paracellular permeability and altered ion selectivity.
Point Mutation
Point mutations can be introduced into tight junction genes to mimic disease-associated variants or to study phosphorylation sites. For example, mutating phosphorylation sites in occludin can reveal their role in junction regulation.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous tight junction genes allows real-time imaging of junction dynamics. This approach is valuable for tracking assembly and disassembly in live cells.
Overexpression
Overexpression of tight junction proteins such as claudins or ZO-1 can enhance barrier function and is used to study their sufficiency in tightening junctions. This is particularly useful for testing therapeutic candidates that aim to restore barrier integrity.
How EDITGENE Supports tight junction Research
Researchers studying tight junction-related genes often need to determine whether a candidate gene is causally involved in barrier function, and CRISPR-based models provide a robust way to establish causality. EDITGENE offers a comprehensive suite of services to generate precisely engineered cell models for tight junction research.
Contact EDITGENE today to design your custom CRISPR model for tight junction research.
Frequently Asked Questions About tight junction
What is a tight junction (GO:0070160)?
A tight junction is a cell-cell junction that seals cells together in an epithelium, preventing even small molecules from leaking across the cell sheet.
What genes are involved in tight junctions?
Key genes include CLDN1-5, OCLN, TJP1-3, and JAM-A/B/C, which encode transmembrane and scaffold proteins.
What is the function of tight junctions?
They regulate paracellular permeability and maintain the barrier between different tissue compartments.
How are tight junctions regulated?
They are regulated by phosphorylation, cytokines, and signaling pathways such as PKC and Rho GTPases.
What diseases are associated with tight junction dysfunction?
Inflammatory bowel disease, celiac disease, biliary diseases, and bacterial meningitis are linked to tight junction defects.
How can I study tight junctions in the lab?
Common methods include TEER, paracellular flux, immunofluorescence, and CRISPR-based gene editing.
What is the role of claudins in tight junctions?
Claudins form the backbone of tight junction strands and determine barrier tightness and ion selectivity.
Can tight junctions be targeted for drug delivery?
Yes, tight junction modulators are being developed to reversibly open the paracellular route for drug absorption.
What is the blood-brain barrier's relationship to tight junctions?
The blood-brain barrier is formed by tight junctions between brain endothelial cells, and their disruption is linked to neuroinflammation.
How does CRISPR help in tight junction research?
CRISPR enables knockout, knock-in, point mutation, and overexpression models to study gene function and identify therapeutic targets.
Conclusion
Tight junctions (GO:0070160) are essential for epithelial and endothelial barrier function, and their dysregulation underlies numerous human diseases. Advances in CRISPR-based gene editing have accelerated the functional dissection of tight junction components and their regulators. EDITGENE provides comprehensive CRISPR services to support researchers in this field, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Horowitz A et al.. 2023. Paracellular permeability and tight junction regulation in gut health and disease.. Nat Rev Gastroenterol Hepatol 20(7):417-432 PMID: 37186118
- 2. Otani T et al.. 2020. Tight Junction Structure and Function Revisited.. Trends Cell Biol 30(10):805-817 PMID: 32891490
- 3. Merlen G et al.. 2024. Tight junction proteins and biliary diseases.. Curr Opin Gastroenterol 40(2):70-76 PMID: 38260939
- 4. Brunner J et al.. 2021. Target specific tight junction modulators.. Adv Drug Deliv Rev 171:266-288 PMID: 33617902
- 5. Saito AC et al.. 2023. Tight-junction strand networks and tightness of the epithelial barrier.. Microscopy (Oxf) 72(3):213-225 PMID: 36715075
- 6. Al-Obaidi MMJ et al.. 2025. Tight Junction Proteins and Bacterial Pathogens Impacting the Brain.. Eur J Neurosci 62(11):e70340 PMID: 41318968
- 7. Sawada N. 2013. Tight junction-related human diseases.. Pathol Int 63(1):1-12 PMID: 23356220
- 8. Jauregi-Miguel A. 2021. The tight junction and the epithelial barrier in coeliac disease.. Int Rev Cell Mol Biol 358:105-132 PMID: 33707052
